Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11101
PUT
CareDx
CDNA
$3.26B
| $124K | ﹤0.01% |
5,800
-4,100
| -41% | -$99.7K |
2022 Q4
8 quarters
|
|
11102
CALL
Amprius Technologies
AMPX
$1.33B
| $124K | ﹤0.01% |
44,200
+31,100
| +237% | +$54.3K |
2023 Q3
5 quarters
|
|
11103
iShares MSCI Indonesia ETF
EIDO
$415M
| $124K | ﹤0.01% |
6,690
-21,010
| -76% | -$434K |
2021 Q4
12 quarters
|
|
|
ENFN
11104
CALL
DELISTED
Enfusion, Inc.
ENFN
| $124K | ﹤0.01% |
12,000
+4,900
| +69% | +$47.4K |
2022 Q4
8 quarters
|
|
11105
CALL
ARS Pharmaceuticals
SPRY
$422M
| $123K | ﹤0.01% |
11,700
+9,100
| +350% | +$127K |
2022 Q2
10 quarters
|
|
|
PMO
11106
Franklin Municipal Opportunities Trust
PMO
$254M
| $123K | ﹤0.01% |
12,176
+1,059
| +10% | +$11.1K |
2024 Q3
1 quarter
|
|
|
MAXN
11107
PUT
DELISTED
Maxeon Solar Technologies
MAXN
| $123K | ﹤0.01% |
16,316
-1,752
| -10% | -$13.6K |
2020 Q3
17 quarters
|
|
11108
Flowers Foods
FLO
$1.22B
| $123K | ﹤0.01% |
+5,953
| New | +$131K |
2024 Q4
0 quarters
|
|
11109
PUT
YieldMax AI Option Income Strategy ETF
AIYY
$45M
| $123K | ﹤0.01% |
1,440
+860
| +148% | +$81.3K |
2024 Q2
2 quarters
|
|
|
BERY
11110
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $123K | ﹤0.01% |
1,900
-42,640
| -96% | -$2.81M |
2016 Q4
32 quarters
|
|
|
SWTX
11111
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $123K | ﹤0.01% |
3,400
-5,400
| -61% | -$189K |
2022 Q1
11 quarters
|
|
11112
PUT
United States Brent Oil Fund
BNO
$795M
| $123K | ﹤0.01% |
4,100
-4,000
| -49% | -$118K |
2020 Q2
18 quarters
|
|
11113
PUT
Anterix
ATEX
$1.56B
| $123K | ﹤0.01% |
4,000
+1,500
| +60% | +$49.9K |
2022 Q4
8 quarters
|
|
11114
CALL
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $122K | ﹤0.01% |
4,600
-600
| -12% | -$16.9K |
2021 Q4
12 quarters
|
|
11115
Atlas Lithium Corp
ATLX
$71M
| $122K | ﹤0.01% |
+19,320
| New | +$147K |
2024 Q4
0 quarters
|
|
11116
CALL
ReNew
RNW
$2.51B
| $122K | ﹤0.01% |
17,900
-2,800
| -14% | -$17K |
2021 Q3
13 quarters
|
|
11117
CALL
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$630M
| $122K | ﹤0.01% |
1,600
+1,200
| +300% | +$95.8K |
2022 Q2
10 quarters
|
|
|
DOG
11118
CALL
ProShares Short Dow30
DOG
$109M
| $122K | ﹤0.01% |
4,600
+4,400
| +2,200% | +$116K |
2024 Q3
1 quarter
|
|
11119
PUT
BioLife Solutions
BLFS
| $122K | ﹤0.01% |
4,700
+700
| +18% | +$17.4K |
2020 Q4
16 quarters
|
|
11120
CALL
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.5B
| $122K | ﹤0.01% |
2,200
-5,000
| -69% | -$294K |
2022 Q4
8 quarters
|
|
11121
CALL
Bright Horizons
BFAM
$3.28B
| $122K | ﹤0.01% |
1,100
-12,600
| -92% | -$1.52M |
2020 Q3
17 quarters
|
|
11122
CALL
Phathom Pharmaceuticals
PHAT
$547M
| $122K | ﹤0.01% |
15,000
-3,200
| -18% | -$39.6K |
2022 Q1
11 quarters
|
|
|
LPRO
11123
CALL
DELISTED
Open Lending Corp
LPRO
| $122K | ﹤0.01% |
20,400
-8,400
| -29% | -$50.3K |
2020 Q4
16 quarters
|
|
|
HYAC
11124
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $122K | ﹤0.01% |
+11,302
| New | +$121K |
2024 Q4
0 quarters
|
|
|
TRVG
11125
trivago
TRVG
$306M
| $122K | ﹤0.01% |
55,783
-5,177
| -8% | -$9.99K |
2016 Q4
32 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.